Groundbreaking Oncology Epidemiology & Drug Treatment Forecasting Tool from Datamonitor

  • 793 views
Uploaded on

Datamonitor\'s new premium tool, "DiseaseFocus Oncology," includes epidemiology and drug treatment forecasts which are designed to reliably assess the current & future magnitude of …

Datamonitor\'s new premium tool, "DiseaseFocus Oncology," includes epidemiology and drug treatment forecasts which are designed to reliably assess the current & future magnitude of patient treatment opportunities across multiple cancer types in the seven major markets. Tumors covered include: Prosate, Breast, NSCLC, NHL, Bladder, Colon & Rectal, Multiple Myeloma, and Renal Cell Carcinoma

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
793
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Access superior oncology epidemiology and treatment data with DiseaseFocus The DiseaseFocus portfolio includes epidemiology (EpiFocus) and drug treatment (TreatmentFocus) forecasts which are designed to reliably assess the current and future magnitude of patient treatment opportunities across multiple cancer types in seven major markets. Why does DiseaseFocus offer How will data with Greater Accuracy Greater Accuracy? help me? Datamonitor identified a gap in the market for a robust With more accurate data, DiseaseFocus allows you to make bottom-up forecasting technique that provides pharmaceutical crucial business decisions from a position of strength. companies with more accurate data and greater granularity. Our audited techniques are unique in a market dominated by top • Better prioritization of drug development and clinical trials down general forecasts. • Deploy resources to where they will generate the most return Patients on drug X • Rank indications and patient segments based on more TreatmentFocus accurate figures of current size and expected growth and value • Gain a full understanding of the threats posed by current Drug-treated patients and future potential competitors based on their drugs – both Bottom-up forecasting currently marketed and in development Treatable population • Accurately evaluate in- or out-licensing opportunities EpiFocus Population with disease Total population
  • 2. EpiFocus Database The EpiFocus Database is Datamonitor’s proprietary epidemiology database providing robust and comprehensive epidemiologic data for the seven major healthcare markets, forecast over a ten-year period. Our epidemiology product is uniquely packaged to allow you to maximize the potential of our extensive patient-level and population- level data. You can choose from a variety of epidemiologic measures and variables to create your own tailored data outputs. All data has been rigorously assessed for robustness and validated for accuracy by our team of highly qualified and experienced epidemiologists, so you can be sure that you are working with trustworthy information. TreatmentFocus Database The TreatmentFocus Database provides comprehensive treatment data for the seven major healthcare markets, forecast over a ten-year period. The TreatmentFocus Database uses the principles of bottom up forecasting based on Datamonitor’s proprietary epidemiology offering (EpiFocus). The TreatmentFocus Database is designed to facilitate easy access to comprehensive drug prescribing patterns across the seven major healthcare markets. You can view the data by tumor type or by a single drug molecule segmented by clinically relevant populations. Multiple data sources have been carefully selected and validated to build an accurate picture of current and future clinical practice. All forecast assumptions are explained in detail and can be accessed from the TreatmentFocus Database front page. Meet our Accuracy Experts Lulit Solomon Andrew Paramore Global Director of Epidemiology Head of Oncology Product Development PhD and MPhil in Epidemiology (Cambridge University) MRPhamS Lulit has extensive expertise in epidemiologic methods and Andrew has a BSc in Pharmacy and is currently studying for analyses, with cross-disease experience and in-depth cancer an MSc in Clinical Oncology at Birmingham University. He has epidemiology knowledge. extensive experience in oncology and haematology gained during his time as a senior pharmacist at the Royal Marsden Previously Lulit was Principal Epidemiologist at Decision NHS Trust. He has pharmaceutical industry experience with Resources where she was the in-house expert on epidemiology a number of positions at GSK and Amgen UK. He has also and supported the multi-syndicated and consulting businesses. worked as a Healthcare Analyst specialising in oncology with Lulit has also undertaken a variety of health strategy research Decision Resources. and consulting projects in a number of countries including the UK, Canada, Malawi, Kenya, and Uganda. As a former Honorary Fellow of the Cancer Intelligence Unit at Cambridge University, Lulit maintains her strong academic links in the field of epidemiology. Free For more information on DiseaseFocus or to arrange Demo a free demo please contact demo@datamonitor.com